Strategic partnership between BEGO Implant Systems and NovaBone

BEGO Implant Systems, a leading provider of dental implant systems with a long tradition in dentistry, and NovaBone, a pioneer in the field of innovative bone graft substitutes, announce their strategic partnership. As part of this agreement, BEGO Implant Systems will take over the distribution of NovaBone products in Europe.

This partnership has the common goal of improving the availability and accessibility of advanced bone grafting materials for dentists, implantologists and patients across Europe. NovaBone is internationally recognized for its high-quality, biocompatible materials that enable optimal bone regeneration. The products are characterized by advanced technology, clinically proven results and ease of use.

"The partnership with NovaBone expands our portfolio in the field of dental regeneration materials and offers our customers an even broader range of solutions for implant restoration," explains Steffen Böhm, Chief Product Officer BEGO Group. "We look forward to combining NovaBone's expertise with our comprehensive distribution structure to further enhance the quality of treatment for patients."

NovaBone is also optimistic: "With BEGO Implant Systems, we have a partner at our side who not only has extensive market knowledge, but also enjoys an excellent reputation for high-quality products and innovative solutions," says Scott Day, NovaBone spokesman.

Both companies are convinced that this strategic alliance will have a lasting impact on the market for regenerative materials - to the benefit of users and patients alike.

For further information please visit:

About BEGO Implant Systems

BEGO Implant Systems is a provider of dental implantology products based in Bremen, Germany. The company combines state-of-the-art technology with decades of experience and offers high-quality solutions for dentists and patients.

About NovaBone

NovaBone is a developer and manufacturer of bone graft substitutes based in the USA. The company sets the standard in bone regeneration technology with clinically proven products for the global market.

Scott Day, Sr. Director, Business Development & Private Label
Scott Day, Sr. Director, Business Development & Private Label
Steffen Böhm, Chief Product Officer
Steffen Böhm, Chief Product Officer